全球智慧吸入器市场规模、份额、成长分析、按类型（干粉吸入器和计量吸入器）、按配销通路、按最终用途 - 2024-2031 年行业预测

2022年全球智慧吸入器市场规模为122.2亿美元，预计将从2023年的146.4亿美元成长到2031年的621.1亿美元，在预测期内（2024-2031年）复合年增长率为19.8%。

快速扩张的全球智慧吸入器市场（医疗保健领域的一个部门）正在彻底改变包括气喘和慢性阻塞性肺病在内的呼吸系统疾病的治疗。智慧吸入器是一种使用感测器和蓝牙技术追踪和监控患者吸入器使用的医疗设备。医疗保健专业人员可以使用智慧吸入器收集的资料来更好地监测患者对处方时间表的遵守情况，并根据需要修改治疗策略。透过允许医疗保健从业人员监测患者药物使用情况并即时调整治疗计划，该行业旨在提高呼吸系统疾病治疗的功效和效率。

目录

执行摘要

• 市场概况
• 命运之轮

研究方法论

• 资讯采购
• 二手和主要资料来源
• 市场规模估计
• 市场假设与限制

母公司市场分析

• 市场概况
• 市场规模
• 市场动态
  • 司机
  • 机会
  • 限制
  • 挑战

主要市场洞察

• 技术分析
• 定价分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• 启动分析
• 原料分析
• 创新矩阵
• 管道产品分析
• 总体经济指标
• 顶级投资分析
• 成功的关键因素
• 竞争程度

市场动态与展望

• 市场动态
  • 司机
  • 机会
  • 限制
  • 挑战
• 监管环境
• 波特分析
• 对未来颠覆的特别见解

按类型分類的全球智慧吸入器市场

• 市场概况
• 干粉吸入器 (DPI) 和定量吸入器 (MDI)

按配销通路分類的全球智慧吸入器市场

• 市场概况
• 医院药房
• 零售药局
• 网路药局

全球智慧吸入器市场（按最终用途）

• 市场概况
• 医院
• 家庭护理设置
• 和别的

全球智慧吸入器市场规模（按地区）

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 拉丁美洲其他地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • MEA 的其余部分

竞争格局

• 前 5 名玩家比较
• 2021 年关键参与者的市场定位
• 主要市场参与者所采取的策略
• 最佳制胜策略
• 近期市集活动
• 主要公司市占率（%），2021年

主要公司简介

• Teva Pharmaceuticals (Israel)
• GlaxoSmithKline (UK)
• Novartis (Switzerland)
• AstraZeneca (UK)
• Boehringer Ingelheim (Germany)
• Philips Respironics (US)
• Propeller Health (US)
• Vectura Group (UK)
• Opko Health (US)
• Adherium Limited (New Zealand)
• AptarGroup (US)
• Cohero Health (US)
• H&T Presspart (UK)
• 3M Company (US)
• Cipla (India)
• Mundipharma (UK)
• Glenmark Pharmaceuticals (India)
• Chiesi Farmaceutici (Italy)
• Propeller Health (US)
• Sensirion AG (Switzerland)

Global Smart Inhalers Market size was valued at USD 12.22 billion in 2022 and is poised to grow from USD 14.64 billion in 2023 to USD 62.11 billion by 2031, growing at a CAGR of 19.8% during the forecast period (2024-2031).

The treatment of respiratory conditions including asthma and COPD is being revolutionized by the quickly expanding global smart inhalers market, a sector of the healthcare sector. Smart inhalers are medical devices that track and monitor patients' inhaler usage using sensors and Bluetooth technology. Healthcare professionals can use the data that smart inhalers collect to better monitor patient adherence to prescription schedules and modify treatment strategies as necessary. By allowing healthcare practitioners to monitor patient drug usage and make real-time treatment plan adjustments, the industry aims to improve the efficacy and efficiency of respiratory disease therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Inhalers Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Inhalers Market Segmental Analysis

Global Smart Inhalers Market is segmented on the basis of type, distribution channel, end-use, and region. By type, the market is segmented into dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. By end-use, the market is segmented into hospitals, homecare settings, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Smart Inhalers Market

Innovations in technology are a major factor propelling the market for smart inhalers. The treatment of respiratory disorders has changed dramatically as a result of the introduction of sophisticated sensors, networking choices, and data analytics tools. Personalized treatment and better patient outcomes are made possible by smart inhalers' ability to gather and communicate data in real-time to healthcare practitioners about medicine usage, inhaler technique, and environmental variables. One digital therapeutics startup, Propeller Health, has created a sensor-based smart inhaler platform. The platform is made up of a sensor that fits onto common inhalers and monitors drug intake. The gathered information is transferred to a smartphone app, which gives patients and medical professionals information and alerts.

Restraints in the Global Smart Inhalers Market

The comparatively expensive price of smart inhalers in comparison to traditional inhalers is one of the market's limitations. Smart inhalers are more expensive because of their sophisticated technology and connection features. Their broad adoption may be constrained by their cost, especially in areas with scarce healthcare resources and affordability issues. For instance, the cost of a smart inhaler might vary from $100 to $300, based on the features and brand. Patients with low incomes or no insurance may find this increased expense to be problematic. Because of this, the market growth of smart inhalers may be hampered in some markets where their adoption is delayed.

Market Trends of the Global Smart Inhalers Market

The incorporation of machine learning (ML) and artificial intelligence (AI) algorithms into inhaler technology is a significant trend in the smart inhalers market. Large datasets gathered from smart inhalers can be analyzed by AI and ML approaches, which can also spot trends and offer predictive insights. This makes it possible for medical professionals to anticipate exacerbations, optimize medicine dosage, and customize treatment regimens. For instance, the digital health startup Cohero Health has created a smart inhaler system that uses ML and AI algorithms. In order to give patients and healthcare professionals individualized recommendations and real-time feedback, the system examines inhaler usage trends, environmental data, and patient-specific information. This trend demonstrates how AI and ML can be used to improve patient outcomes and the management of respiratory diseases.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Smart Inhalers Market by Type

• Market Overview
• Dry powdered inhalers (DPIs) and metered dose inhalers (MDIs)

Global Smart Inhalers Market by Distribution Channel

• Market Overview
• Hospital pharmacies
• retail pharmacies
• and online pharmacies

Global Smart Inhalers Market by End-Use

• Market Overview
• Hospitals
• homecare settings
• and others

Global Smart Inhalers Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Teva Pharmaceuticals (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Respironics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Propeller Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vectura Group (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Opko Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adherium Limited (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohero Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• H&T Presspart (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mundipharma (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glenmark Pharmaceuticals (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chiesi Farmaceutici (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Propeller Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensirion AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments